Nektar Therapeutics
NKTR
NKTR
153 hedge funds and large institutions have $1.39B invested in Nektar Therapeutics in 2015 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 65 increasing their positions, 40 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
26% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 35
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
153
Holding in Top 10
–
Calls
$10.4M
Puts
$6.04M
Top Buyers
| 1 | +$19.8M | |
| 2 | +$14.6M | |
| 3 | +$14.2M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$10.6M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$8.34M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$10.5M | |
| 3 | -$8.09M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$5.41M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$5.07M |